BERLIN--(BUSINESS WIRE)--Bayer today announced that a New Drug Application (NDA) for the investigational compound elinzanetant has been submitted to the U.S. Food and Drug Administration (FDA) for the ...
Bayer A.G. stock: contrarian Buy with €35 target. Click for this updated look at BAYZF stock prospects and why I am neutral ...
LEVERKUSEN, Germany--(BUSINESS WIRE)--The Federal Court of Australia brought an end to the last Roundup™ case in Australia, closing all pending injury litigation there. The Court granted the ...
Crop Science faces ongoing challenges and litigation pressures, notably impacting overall group performance. Despite restructuring efforts, Bayer's financial outlook for 2025 remains weak, with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results